These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38874380)

  • 1. Validity of the MoCA as a cognitive screening tool in epilepsy: Are there implications for global care and research?
    Reyes A; Hermann BP; Prabhakaran D; Ferguson L; Almane DN; Shih JJ; Iragui-Madoz VJ; Struck A; Punia V; Jones JE; Busch RM; McDonald CR
    Epilepsia Open; 2024 Aug; 9(4):1526-1537. PubMed ID: 38874380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Validity and Utility of Montreal Cognitive Assessment Domain Scores for Early Neurocognitive Disorders.
    Ang LC; Yap P; Tay SY; Koay WI; Liew TM
    J Am Med Dir Assoc; 2023 Mar; 24(3):314-320.e2. PubMed ID: 36758620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations for interpreting failure on individual subtests of the Montreal Cognitive Assessment.
    Moafmashhadi P; Koski L
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):19-28. PubMed ID: 23385364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montreal Cognitive Assessment (MoCA) XpressO: Validation of a digital self-administered cognitive prescreening tool.
    Klil-Drori S; Bodenstein KC; Sun S; Kojok L; Gruber J; Ghantous Y; Cummings J; Nasreddine Z
    J Am Geriatr Soc; 2024 Aug; 72(8):2516-2522. PubMed ID: 38558263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) to frontal lobe epilepsy using multicenter data.
    Arrotta K; Swanson SJ; Janecek JK; Hamberger MJ; Barr WB; Baxendale S; McDonald CR; Reyes A; Hermann BP; Busch RM
    Epilepsy Behav; 2023 Nov; 148():109471. PubMed ID: 37866248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Cutoff of the MoCA too High? Longitudinal Data From Highly Educated Older Adults.
    Elkana O; Tal N; Oren N; Soffer S; Ash EL
    J Geriatr Psychiatry Neurol; 2020 May; 33(3):155-160. PubMed ID: 31500493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong.
    Yeung PY; Wong LL; Chan CC; Leung JL; Yung CY
    Hong Kong Med J; 2014 Dec; 20(6):504-10. PubMed ID: 25125421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Montreal cognitive assessment culturally valid in a diverse geriatric primary care setting? Lessons from the Bronx.
    Stimmel MB; Orkaby AR; Ayers E; Verghese J; Nsubayi CK; Weiss EF
    J Am Geriatr Soc; 2024 Mar; 72(3):850-857. PubMed ID: 38196332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the cross-cultural applicability of a harmonized approach to cognitive diagnostics in epilepsy: Initial results of the International Classification of Cognitive Disorders in Epilepsy in a Spanish-speaking sample.
    Reyes A; Salinas L; Hermann BP; Baxendale S; Busch RM; Barr WB; McDonald CR
    Epilepsia; 2023 Mar; 64(3):728-741. PubMed ID: 36625416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool.
    Novak A; Vizjak K; Gacnik A; Rakusa M
    Acta Neurol Belg; 2023 Apr; 123(2):451-456. PubMed ID: 35925540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic
    Wood JL; Weintraub S; Coventry C; Xu J; Zhang H; Rogalski E; Mesulam MM; Gefen T
    J Int Neuropsychol Soc; 2020 Oct; 26(9):927-931. PubMed ID: 32423505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.
    Gallucci L; Sperber C; Monsch AU; Klöppel S; Arnold M; Umarova RM
    Sci Rep; 2024 Aug; 14(1):20125. PubMed ID: 39209968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.